OpenAlex
PricingAboutJobs
Log inGet started
Work

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

HTML PDF

Year: 2005
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdj084
Authors: G. Folprecht, M.P. Lutz, P. Schöffski, T. Seufferlein, A. Nolting, P. Pollert, C.-H. Köhne
Institutions: University Hospital Carl Gustav Carus, University Hospital Ulm, Medizinische Hochschule Hannover, Merck KGaA, Darmstadt (Germany), Klinikum Oldenburg
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cetuximab, irinotecan, 5-fluorouracil, leucovorin, metastatic colorectal cancer, first-line chemotherapy, drug safety and tolerability, dose-limiting toxicity, acne-like rash, diarrhea, combination chemotherapy, time to progression, survival, treatment response
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2134920919
FWCI: 16.2
Cites: 34
Cited by: 246
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms